Project Details
Description
A Phase I Study of HCW9218, a Bifunctional TGF-? Antagonist/IL-15 Protein Complex, in Select Advanced Solid Tumors After Failing at Least Two Prior Therapies
| Status | Active |
|---|---|
| Effective start/end date | 1/21/22 → 1/31/26 |
Funding
- HCW BIOLOGICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.